Greylin Investment Mangement Inc Eli Lilly & CO Transaction History

Greylin Investment Mangement Inc

$590 Million
Q1 2024

A detailed history of Greylin Investment Mangement Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 7,425 shares of LLY stock, worth $6.72 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

7,425

Previous 8,475 12.39%

Holding current value

$6.72 Million

Previous $4.94 Million 16.92%

% of portfolio

0.98%

Previous 0.89%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $621,810 - $831,894	-1,050 Reduced 12.39%	7,425 $5.78 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $170,686 - $201,217	-325 Reduced 3.69%	8,475 $4.94 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $2.43 Million - $3.35 Million	-5,585 Reduced 38.83%	8,800 $4.73 Million
Q2 2023 Jul 10, 2023	SELL	$350.74 - $468.98 $52,611 - $70,347	-150 Reduced 1.03%	14,385 $6.75 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $28,939 - $33,720	-90 Reduced 0.62%	14,535 $0

Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $686,351 - $782,169	-2,315 Reduced 13.67%	14,625 $4.73 Million
Q2 2022 Jul 11, 2022	SELL	$278.73 - $327.27 $61,320 - $71,999	-220 Reduced 1.28%	16,940 $5.49 Million
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $11,080 - $13,635	50 Added 0.29%	17,160 $3.97 Million
Q2 2021 Jul 14, 2021	SELL	$180.55 - $233.54 $12,638 - $16,347	-70 Reduced 0.41%	17,110 $3.93 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $41,080 - $53,180	-250 Reduced 1.43%	17,180 $3.21 Million
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $19,569 - $25,894	-150 Reduced 0.85%	17,430 $2.94 Million
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $140,371 - $162,364	-960 Reduced 5.18%	17,580 $2.6 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $111,864 - $134,627	-820 Reduced 4.24%	18,540 $3.04 Million
Q1 2020 Apr 09, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 0.51%	19,360 $2.69 Million
Q4 2019 Jan 09, 2020	SELL	$106.92 - $132.43 $48,114 - $59,593	-450 Reduced 2.26%	19,460 $2.56 Million
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $305,780 - $356,923	-2,760 Reduced 12.17%	19,910 $2.21 Million
Q1 2019 Apr 09, 2019	SELL	$111.31 - $131.02 $330,590 - $389,129	-2,970 Reduced 11.58%	22,670 $2.94 Million
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $60,892 - $68,218	-575 Reduced 2.19%	25,640 $2.97 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $85,860 - $107,310	-1,000 Reduced 3.67%	26,215 $2.81 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $14,841 - $17,520	200 Added 0.74%	27,215 $2.11 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.08 Million - $2.31 Million	27,015	27,015 $2.31 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Account

Greylin Investment Mangement Inc Eli Lilly & CO Transaction History